Cargando…

Generation of the Fip1l1–Pdgfra fusion gene using CRISPR/Cas genome editing

Detalles Bibliográficos
Autores principales:	Vanden Bempt, M, Demeyer, S, Mentens, N, Geerdens, E, De Bock, C E, Wlodarska, I, Cools, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240015/ https://www.ncbi.nlm.nih.gov/pubmed/27021554 http://dx.doi.org/10.1038/leu.2016.62

Ejemplares similares

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report
por: Ali, Salhah, et al.
Publicado: (2022)

Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA rearrangement
por: Kim, Tae Hee, et al.
Publicado: (2016)

Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified
por: Debackere, Koen, et al.
Publicado: (2021)

FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia
por: Loules, Gedeon, et al.
Publicado: (2009)

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene
por: van der Krogt, Jo-Anne, et al.
Publicado: (2017)

EML1–ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant Model
por: Vanden Bempt, Marlies, et al.
Publicado: (2018)

FIP1L1-PDGFRA Clonal Hypereosinophilic Syndrome With Eosinophilic Myocarditis and Intracardiac Thrombus
por: Locke, Margaret, et al.
Publicado: (2023)

Lyn mediates FIP1L1-PDGFRA signal pathway facilitating IL-5RA intracellular signal through FIP1L1-PDGFRA/JAK2/Lyn/Akt network complex in CEL
por: Li, Bin, et al.
Publicado: (2016)

Ascites in a young male: idiopathic FIP1L1-PDGFRA-negative hypereosinophilic syndrome
por: Kasinathan, Ganesh, et al.
Publicado: (2020)

Pruritus as a Presenting Symptom of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia
por: Abu-Tineh, Mohammad, et al.
Publicado: (2021)

Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report
por: Yamamoto, Masayo, et al.
Publicado: (2017)

Chronic eosinophilic leukemia with FIP1L1-PDGFRA transcripts after occupational and therapeutic exposure to radiation
por: Balatzenko, Gueorgui, et al.
Publicado: (2011)

An Intriguing Case of Eosinophilia with FIP1L1/PDGFRA Rearrangement Who Presented as Thrombotic Thrombocytopenic Purpura
por: Alshehri, Hassan, et al.
Publicado: (2019)

Identification of JAK2 as a Mediator of FIP1L1-PDGFRA-Induced Eosinophil Growth and Function in CEL
por: Li, Bin, et al.
Publicado: (2012)

Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing
por: Mandelker, Diana, et al.
Publicado: (2015)

Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
por: Kim, Dae Sik, et al.
Publicado: (2018)

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases
por: Legrand, Fanny, et al.
Publicado: (2013)

Chronic eosinophilic leukemia with a FIP1L1-PDGFRA rearrangement: Two case reports and a review of Korean cases
por: Shin, Sang-Yong, et al.
Publicado: (2015)

Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia
por: Shah, Shilpan, et al.
Publicado: (2014)

Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system
por: Bornschein, S, et al.
Publicado: (2018)

TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia
por: Thielemans, Naomi, et al.
Publicado: (2022)

Rapid genome editing by CRISPR-Cas9-POLD3 fusion
por: Reint, Ganna, et al.
Publicado: (2021)

Long-term outcomes of imatinib in patients with FIP1L1/PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China
por: Qu, Shi-Qiang, et al.
Publicado: (2016)

An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement
por: Farah, Sassi, et al.
Publicado: (2022)

Generation of sas-6::ha by CRISPR/Cas9 editing
por: Bergwell, Mary, et al.
Publicado: (2019)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

P1297: ABERRANT MYCN EXPRESSION DRIVES ONCOGENIC HIJACKING OF EZH2 AS A TRANSCRIPTIONAL ACTIVATOR IN PERIPHERAL T CELL LYMPHOMA
por: Vanden Bempt, M., et al.
Publicado: (2022)

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia
por: Jain, Juhi, et al.
Publicado: (2020)

Generation of PCBP1-deficient pigs using CRISPR/Cas9-mediated gene editing
por: Qi, Chunyun, et al.
Publicado: (2022)

Editorial: Next-Generation Sequencing and CRISPR-Cas Editing in Plant Virology
por: Hadidi, Ahmed, et al.
Publicado: (2021)

Conditional CRISPR-Cas Genome Editing in Drosophila to Generate Intestinal Tumors
por: Bahuguna, Shivohum, et al.
Publicado: (2021)

A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing
por: Koppes, Erik A., et al.
Publicado: (2020)

One-Step Homology Mediated CRISPR-Cas Editing in Zygotes for Generating Genome Edited Cattle
por: Park, Ki-Eun, et al.
Publicado: (2020)

The Rab11 effectors Fip5 and Fip1 regulate zebrafish intestinal development
por: Jewett, Cayla E., et al.
Publicado: (2020)

Enhanced genome editing efficiency of CRISPR PLUS: Cas9 chimeric fusion proteins
por: Park, Jongjin, et al.
Publicado: (2021)

CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
por: Panfil, Amanda R., et al.
Publicado: (2018)

Genome Editing Using Cas9 Ribonucleoprotein Is Effective for Introducing PDGFRA Variant in Cultured Human Glioblastoma Cell Lines
por: Hamada, Taiji, et al.
Publicado: (2022)

Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
por: Dimitri, Alexander, et al.
Publicado: (2022)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o97s1m0golptm8knpn751ovaah